Processa Pharmaceuticals Statistics
Total Valuation
PCSA has a market cap or net worth of $3.61 million. The enterprise value is $950,865.
Important Dates
The last earnings date was Wednesday, October 30, 2024, after market close.
Earnings Date | Oct 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PCSA has 3.26 million shares outstanding. The number of shares has increased by 117.51% in one year.
Shares Outstanding | 3.26M |
Shares Change (YoY) | +117.51% |
Shares Change (QoQ) | +9.81% |
Owned by Insiders (%) | 5.82% |
Owned by Institutions (%) | 1.38% |
Float | 2.89M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.01 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.03.
Current Ratio | 3.97 |
Quick Ratio | 2.37 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -211.71% and return on invested capital (ROIC) is -132.05%.
Return on Equity (ROE) | -211.71% |
Return on Assets (ROA) | -113.11% |
Return on Capital (ROIC) | -132.05% |
Revenue Per Employee | n/a |
Profits Per Employee | -$886,642 |
Employee Count | 13 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.05% in the last 52 weeks. The beta is 0.60, so PCSA's price volatility has been lower than the market average.
Beta (5Y) | 0.60 |
52-Week Price Change | -84.05% |
50-Day Moving Average | 1.33 |
200-Day Moving Average | 1.86 |
Relative Strength Index (RSI) | 32.43 |
Average Volume (20 Days) | 29,993 |
Short Selling Information
The latest short interest is 163,575, so 5.02% of the outstanding shares have been sold short.
Short Interest | 163,575 |
Short Previous Month | 61,941 |
Short % of Shares Out | 5.02% |
Short % of Float | 5.67% |
Short Ratio (days to cover) | 1.19 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -11.79M |
Pretax Income | -9.83M |
Net Income | -11.53M |
EBITDA | -11.79M |
EBIT | -11.79M |
Earnings Per Share (EPS) | -$4.55 |
Full Income Statement Balance Sheet
The company has $2.89 million in cash and $96,844 in debt, giving a net cash position of $2.79 million or $0.86 per share.
Cash & Cash Equivalents | 2.89M |
Total Debt | 96,844 |
Net Cash | 2.79M |
Net Cash Per Share | $0.86 |
Equity (Book Value) | 3.72M |
Book Value Per Share | 1.14 |
Working Capital | 3.62M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$11.12 million and capital expenditures -$3,244, giving a free cash flow of -$11.12 million.
Operating Cash Flow | -11.12M |
Capital Expenditures | -3,244 |
Free Cash Flow | -11.12M |
FCF Per Share | -$3.42 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PCSA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -117.51% |
Shareholder Yield | -117.51% |
Earnings Yield | -307.74% |
FCF Yield | -297.01% |
Analyst Forecast
The average price target for PCSA is $5.00, which is 350.49% higher than the current price. The consensus rating is "Buy".
Price Target | $5.00 |
Price Target Difference | 350.49% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on January 22, 2024. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Jan 22, 2024 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |